Vivek Ramaswamy displayed his brilliance by writing his first computer program at the age of 6.

Vivek Ramaswamy earned degrees from Harvard University and Yale Law School, excelling in both academia and leadership roles. 

Vivek Ramaswamy attributes his success to the guidance of his mentor, Dr. P. Roy Vagelos, a renowned scientist and philanthropist.

Vivek Ramaswamy was on track to become a doctor, but his passion for business led him in a different direction. 

Vivek Ramaswamy made history on Wall Street by leading the largest-ever biotech IPO at the time, raising a staggering $2.7 billion.

Vivek Ramaswamy founded Roivant Sciences, a pharmaceutical tech company, and grew it into a multibillion-dollar venture.

Vivek Ramaswamy is an outspoken advocate for diversity and inclusion in the biopharmaceutical industry.

Vivek Ramaswamy is deeply involved in philanthropy, supporting causes related to education, healthcare, and social justice. 

Vivek Ramaswamy has a knack for spotting potential in unexpected places, making strategic investments in various industries with remarkable outcomes. 

Vivek Ramaswamy’s unconventional approach to drug development challenges traditional norms, revolutionising how medicines are brought to market. 

Vivek Ramaswamy actively addresses climate change and environmental issues through his involvement in sustainable initiatives and investments.

Vivek Ramaswamy's impact extends internationally, as he collaborates with experts worldwide to drive innovation and progress in the biotech sector.